Glaxo extends cost cut plan as net surges
February 04, 2010 at 07:57 AM EST
GlaxoSmithKline on Thursday announces further cost cuts as Europe’s largest drugmaker reported a 66% surge in fourth-quarter profit as sales of pandemic flu-related products surge.
